open access
Prolonged QTc interval as a side effect of concomitant administration of CDK4/6 inhibitor and cytochrome P-450 enzyme inhibitors
Affiliations- Department of Clinical Oncology, The Maria Skłodowska-Curie National Research Institute of Oncology, Krakow Branch, Krakow, Poland
- Department of Coronary Disease and Heart Failure, Jagiellonian University Medical College, John Paul II Hospital, Krakow, Poland
open access
Abstract
Abstract
About this articleTitle
Prolonged QTc interval as a side effect of concomitant administration of CDK4/6 inhibitor and cytochrome P-450 enzyme inhibitors
Journal
Nowotwory. Journal of Oncology
Issue
Article type
Pictures in Oncology
Published online
2022-05-25
Page views
13
Article views/downloads
17
DOI
10.5603/NJO.a2022.0032
Authors
Aleksandra Grela-Wojewoda
Mirosława Puskulluoglu
Joanna Lompart
Marek Ziobro
Ewa Konduracka
References (2)- Grela-Wojewoda A, Pacholczak-Madej R, Adamczyk A, et al. Cardiotoxicity Induced by Protein Kinase Inhibitors in Patients with Cancer. Int J Mol Sci. 2022; 23(5): 2815.
- Rascon K, Flajc G, De Angelis C, et al. Ribociclib in HR+/HER2- Advanced or Metastatic Breast Cancer Patients. Ann Pharmacother. 2019; 53(5): 501–509.